Mycophenolic Acid

"Mycophenolic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.

Descriptor ID	D009173
MeSH Number(s)	D02.241.081.193.678 D10.251.618
Concept/Terms	Mycophenolic Acid Mycophenolic Acid Mycophenolate Mofetil Mycophenolate Mofetil Mofetil, Mycophenolate Mycophenolic Acid Morpholinoethyl Ester Cellcept Cellcept Mycophenolate Sodium Mycophenolate Sodium Sodium Mycophenolate Mycophenolate, Sodium Myfortic Myfortic Mycophenolate Mofetil Hydrochloride Mycophenolate Mofetil Hydrochloride Mofetil Hydrochloride, Mycophenolate RS 61443 RS 61443 RS-61443 RS61443

Below are MeSH descriptors whose meaning is more general than "Mycophenolic Acid".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Carboxylic Acids [D02.241]
Acids, Acyclic [D02.241.081]
Caproates [D02.241.081.193]
Mycophenolic Acid [D02.241.081.193.678]
Lipids [D10]
Fatty Acids [D10.251]
Mycophenolic Acid [D10.251.618]

Below are MeSH descriptors whose meaning is related to "Mycophenolic Acid".

Below are MeSH descriptors whose meaning is more specific than "Mycophenolic Acid".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mycophenolic Acid" by people in this website by year, and whether "Mycophenolic Acid" was a major or minor topic of these publications.

Bar chart showing 61 publications over 23 distinct years, with a maximum of 7 publications in 1998 and 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	3	0	3
1997	6	0	6
1998	6	1	7
1999	2	2	4
2000	4	0	4
2001	3	1	4
2002	2	1	3
2003	2	0	2
2004	2	0	2
2005	2	0	2
2006	1	0	1
2007	0	1	1
2008	1	0	1
2009	5	2	7
2010	2	1	3
2011	1	1	2
2014	0	2	2
2015	0	1	1
2016	1	0	1
2017	1	1	2
2019	1	0	1
2021	0	1	1
2023	0	1	1

Below are the most recent publications written about "Mycophenolic Acid" by people in Profiles.

Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, Steen VD, Strek ME, Bernstein EJ, Bhatt N, Castelino FV, Chung L, Domsic RT, Flaherty KR, Gupta N, Kahaleh B, Martinez FJ, Morrow LE, Moua T, Patel N, Shlobin OA, Southern BD, Volkmann ER, Khanna D. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6.

View in: PubMed
Tomkins-Tinch CH, Daly JS, Gladden-Young A, Theodoropoulos NM, Madaio MP, Yu N, Vanguri VK, Siddle KJ, Adams G, Krasilnikova LA, Movahedi B, Bozorgzadeh A, Simin K, Lemieux JE, Luban J, Park DJ, MacInnis BL, Sabeti PC, Levitz SM. SARS-CoV-2 Reinfection in a Liver Transplant Recipient. Ann Intern Med. 2021 08; 174(8):1178-1180.

View in: PubMed
Mir R, Shaw HM, Nathan PD. Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis. Melanoma Res. 2019 02; 29(1):102-106.

View in: PubMed
Ioannou P, Tsagkaraki E, Vamvoukaki R, Kouvidou C, Krasagakis K, Chamilos G, Gikas A. Infective endocarditis due to Enterococcus faecalis manifesting as pemphigus foliaceus. Hellenic J Cardiol. 2019 May - Jun; 60(3):202-204.

View in: PubMed
Rastogi U, Sergie Z, Pinney S, Moss N. Recurrence of eosinophilic granulomatosis with polyangitis after orthotopic heart transplant. Am J Transplant. 2018 06; 18(6):1544-1547.

View in: PubMed
Nutan F, Ortega-Loayza AG. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options. J Investig Dermatol Symp Proc. 2017 10; 18(2):S64-S68.

View in: PubMed
Saini N, Nath R, Cerny J. Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination. Ann Hematol. 2017 Sep; 96(9):1563-1568.

View in: PubMed
Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.

View in: PubMed
Mohiuddin MM, Singh AK, Corcoran PC, Thomas Iii ML, Clark T, Lewis BG, Hoyt RF, Eckhaus M, Pierson Iii RN, Belli AJ, Wolf E, Klymiuk N, Phelps C, Reimann KA, Ayares D, Horvath KA. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016 Apr 05; 7:11138.

View in: PubMed
Karam S, Wali RK. Current State of Immunosuppression: Past, Present, and Future. Crit Rev Eukaryot Gene Expr. 2015; 25(2):113-34.

View in: PubMed

People

Explore

Similar Concepts

Top Journals